is the fda going to ban semaglutide bans compounded and tirzepatide on End of Compounded Semaglutide: Why the FDA's Decision Matters for fda stopping compounded tirzepatide – Hims & Hers pulls copycat

Increased appetite and weight gain are common

In addition to these medications, there are combination drugs like Qsymia and Contrave

Ashapkin V, et al

Benefits of GLP-1 Injectables Significant Weight Loss : Clinical trials have shown that individuals using GLP-1 injectables can achieve substantial weight loss, often more than with diet and exercise alone

Other restaurant chains have already launched options that appeal to diners on GLP-1 drugs, even if the medications weren't the key impetus

Specifically, one commenter suggested that CMS consider unpackaging their product, a contrast agent, and believed CMS's reasoning in the CY 2026 OPPS/ASC proposed rule for unpackaging and paying separately for diagnostic radiopharmaceuticals applies equally or even more to their product, since the cost of their product is over 500 times greater than the amount reported for the policy packaged drugs offset associated with the Level II Urology APC